26 medicines held by B. Braun Melsungen AG on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| 1% w/v Lidocaine Hydrochloride Injection BP PA0736/044/001 |
Lidocaine Hydrochloride Monohydrate | B. Braun Melsungen AG | Marketed |
| 2% w/v Lidocaine Hydrochloride Injection BP PA0736/044/002 |
Lidocaine Hydrochloride Monohydrate | B. Braun Melsungen AG | Marketed |
| Ampres 10mg/ml solution for injection PA0736/043/001 |
Chloroprocaine hydrochloride | B. Braun Melsungen AG | Marketed |
| Ampres 20 mg/ml solution for injection PA0736/043/002 |
Chloroprocaine hydrochloride | B. Braun Melsungen AG | Not marketed |
| Dexmedetomidine B. Braun 100 micrograms/ml concentrate for solution for infusion PA0736/042/001 |
Dexmedetomidine | B. Braun Melsungen AG | Marketed |
| Fluconazole 2 mg/ml solution for infusion PA0736/030/001 |
Fluconazole | B. Braun Melsungen AG | Marketed |
| Gelaspan Solution for Infusion PA0736/034/001 |
Succinylated gelatine (= modified fluid gelatine), Sodium chloride, Sodium acetate trihydrate, Potassium chloride, Calcium chloride dihydrate | B. Braun Melsungen AG | Marketed |
| Gelofusine 40mg/ml Solution for Infusion PA0736/011/001 |
Succinylated gelatine (= modified fluid gelatine), Sodium chloride, Sodium hydroxide | B. Braun Melsungen AG | Marketed |
| Ibuprofen B. Braun 200 mg solution for infusion PA0736/041/003 |
Ibuprofen | B. Braun Melsungen AG | Not marketed |
| Ibuprofen B. Braun 400 mg solution for infusion PA0736/041/001 |
Ibuprofen | B. Braun Melsungen AG | Marketed |
| Ibuprofen B. Braun 600 mg solution for infusion PA0736/041/002 |
Ibuprofen | B. Braun Melsungen AG | Not marketed |
| Metronidazole 5 mg/ml solution for infusion PA0736/002/001 |
Metronidazole | B. Braun Melsungen AG | Marketed |
| Nutriflex basal solution for infusion PA0736/005/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Not marketed |
| Nutriflex peri solution for infusion PA0736/006/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Not marketed |
| Nutriflex plus solution for infusion PA0736/007/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Not marketed |
| Nutriflex special solution for infusion PA0736/008/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Not marketed |
| Omeflex peri emulsion for infusion PA0736/033/002 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Marketed |
| Omeflex plus emulsion for infusion PA0736/039/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Marketed |
| Omeflex special emulsion for infusion PA0736/040/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine | B. Braun Melsungen AG | Marketed |
| Omeflex special without electrolytes emulsion for infusion PA0736/038/001 |
Isoleucine, Leucine, Lysine monohydrate, Methionine, Phenylalanine | B. Braun Melsungen AG | Marketed |
| Paracetamol 10mg/ml solution for infusion PA0736/035/001 |
Paracetamol | B. Braun Melsungen AG | Marketed |
| Propofol-Lipuro 1% (10 mg/ml) emulsion for injection or infusion PA0736/018/001 |
Propofol | B. Braun Melsungen AG | Marketed |
| Propofol-Lipuro 1% (10 mg/ml) emulsion for injection or infusion PA0736/018/002 |
Propofol | B. Braun Melsungen AG | Marketed |
| Propofol-Lipuro 2% (20 mg/ml) emulsion for injection or infusion PA0736/018/003 |
Propofol | B. Braun Melsungen AG | Marketed |
| Rocuronium 10 mg/ml solution for injection/infusion PA0736/029/001 |
Rocuronium bromide | B. Braun Melsungen AG | Marketed |
| Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion PA0736/003/001 |
Sodium chloride | B. Braun Melsungen AG | Not marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.